News
Topline data from SERENITY At-Home Phase 3 trial for acute treatment of agitation associated with bipolar disorders or ...
New findings in Neuropsychopharmacology - first to demonstrate that evenamide targets the key site of schizophrenia pathology ...
1don MSN
A glutamate modulator improves schizophrenia-related dysfunction, may open new treatment paths
New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a ...
Psychedelics are increasingly being studied as wonder drugs for psychiatric issues like depression and addiction. Yet ...
Amaha opens India’s first private inpatient mental health hospital in Bangalore, offering trauma-informed, evidence-based ...
Native youth in California face the state's highest suicide rates despite being its smallest ethnic group. Now Medicaid cuts threaten vital Indigenous clinics offering culturally rooted mental health ...
AbbVie (NYSE: ABBV) has long been known for its immunology drugs like Humira, which at one point was the top-selling drug in ...
Detailed price information for Bioxcel Therapeutics Inc (BTAI-Q) from The Globe and Mail including charting and trades.
Q2 2025 Earnings Call Transcript July 31, 2025 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...
Avant Technologies Inc. is an emerging technology company developing solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is ...
Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results